Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports US$ 21.94 Min. order: 1 piece ★★★★★ 5.0 (286 reviews) Sold : Login>>
BPC-157 Explained: Benefits, Risks, and What the Research Actually Shows US$ 29.30 Min. order: 1 piece ★★★★★ 4.2 (140 reviews) Sold : Login>>
TB 500 vs BPC 157: Comprehensive comparison of healing peptides US$ 25.60 Min. order: 1 piece ★★★★★ 4.8 (98 reviews) Sold : Login>>
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept US$ 24.90 Min. order: 1 piece ★★★★★ 4.3 (215 reviews) Sold : Login>>
Emerging Role of Dual GLP-1 and GIP Receptor Agonists | DMSO US$ 25.13 Min. order: 1 piece ★★★★★ 4.3 (142 reviews) Sold : Login>>